Home Ampio Pharmaceuticals

Ampio Pharmaceuticals

In operation
Post-IPO Round
Developer of New Therapies for Inflammatory Diseases

Basic Information

Ampio Pharmaceuticals is a biopharmaceutical company focused on developing new therapies for the treatment of inflammatory diseases. We are advancing immunology-based therapies to provide safe and effective treatments for patients suffering from these conditions.Our lead product, Ampion™, is a biologic drug that harnesses the power of the immune response to address the root causes of inflammatory diseases. Ampion is designed to provide anti-inflammatory relief to safely treat persistent inflammation and improve the lives of individuals with osteoarthritis, respiratory diseases, and other inflammatory conditions.
Ampio Pharmaceuticals, Inc.
Colorado,United States of America
15~50 people
January 01, 2011
info@ampiopharma.com